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Abstract
Background—We examined the contribution of patient, physician, and environmental factors to 
demographic and health variation in colonoscopy follow-up after positive Fecal Occult Blood Test/
Fecal Immunochemical Test (FOBT/FIT+) screening.
Methods—We identified 76,243 FOBT/FIT+ cases from 120 Veterans Health Administration 
(VHA) facilities between 8/16/09–3/20/11 and followed them for 6 months. We identified patient 
demographic (race/ethnicity, gender, age, marital status) and health characteristics (comorbidities); 
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physician characteristics (training level, whether primary care provider) and behaviors 
(inappropriate FOBT/FIT screening); and environmental factors (geographic access, facility type) 
from VHA administrative records. We estimated patient behaviors (refusal, private sector 
colonoscopy use) with statistical text mining conducted on clinic notes. We estimated follow-up 
predictors and adjusted rates using hierarchical logistic regression.
Results—Roughly 50% completed a colonoscopy at a VHA facility within 6 months. Age and 
comorbidity score were negatively associated with follow-up. Blacks were more likely to receive 
follow-up than Whites. Environmental factors attenuated but did not fully account for these 
differences. Patient behaviors (refusal, private sector colonoscopy use), and physician behaviors 
(inappropriate screening) fully accounted for the small reverse race disparity, and attenuated 
variation by age and comorbidity score. Patient behaviors (refusal and private sector colonoscopy 
use) contributed more to variation in follow-up rates than physician behaviors (inappropriate 
screening).
Conclusions—In the VHA, Blacks are more likely to receive colonoscopy follow-up for 
FOBT/FIT+ results than Whites, and follow-up rates markedly decline with advancing age and 
comorbidity burden. Patient and physician behaviors explain race variation in follow-up rates and 
contribute to variation by age and comorbidity burden.
Keywords
Early Detection of Cancer; Diagnostic Services; Mass Screening; Colorectal Neoplasms; 
Colonoscopy; Health Services Accessibility; Veterans Health
BACKGROUND
Colorectal cancer was diagnosed in an estimated 134,490 individuals and resulted in an 
estimated 49,190 deaths in 2016.1 Routine screening can reduce the burden of this disease, 
and the United States Preventive Services Task Force recommends a number of screening 
modalities.2 Fecal occult blood test and fecal immunochemical test-based (FOBT/FIT) 
screening are common modalities in many settings, including the two largest health care 
systems in the United States (Kaiser Permanente and the Veterans Health Administration).3;4 
However, the benefits of FOBT/FIT screening cannot be achieved unless positive results are 
followed by colonoscopy. Prior studies have documented gaps in colonoscopy follow-up 
rates among individuals with a positive FOBT/FIT (FOBT/FIT+), and in many settings less 
than 60% receive follow-up before they are due for repeat screening.5–10 Understanding the 
reasons for these gaps is essential for guiding development of effective strategies for closing 
them.
Prior studies have found lower rates of colonoscopy follow-up for FOBT/FIT+ associated 
with various demographic and health characteristics, including non-African American 
race,11 Hispanic ethnicity,12 female gender,12–14 increasing age,10;13;15;16 and 
comorbidities,10 but it is not clear whether these patterns are due to variation in patient 
behaviors (e.g., refusal), physician behaviors (e.g., potentially inappropriate screening 
among those with limited life expectancy or recent prior colonoscopy), or environmental 
factors such as geographic access to colonoscopy. Two studies found that 14–38% of 
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patients lacking follow-up for FOBT/FIT+ results had documentation of refusal, 
comorbidity or a contraindication that would preclude follow-up testing,8;17 but one of these 
studies was limited to patients age 70 and older17 and neither examined demographic or 
health-related variation in reasons for lack of follow-up. Variation in patient refusal of 
treatment has been found to contribute to age and race differences in receipt of cancer 
therapy,18 but to our knowledge, no studies have examined whether refusal and potentially 
inappropriate screening contribute to demographic and health-related differences in 
colonoscopy follow-up for FOBT/FIT+ results.
This study addresses this gap by examining the contribution of patient behavior (refusal), 
physician behavior (potentially inappropriate FOBT/FIT screening), and environmental 
factors (access) to demographic and health variation in colonoscopy following a positive 
FOBT/FIT in a sample of adults age 50–85 receiving care at a VHA facility. We 
hypothesized that any observed differences in follow-up rates by patient age, race, and 
comorbidities would be explained by variation in refusal, inappropriate screening, and 
access.
METHODS
Setting and Participants
We identified patients receiving FOBT/FIT+ results from one of 120 eligible VHA facilities 
between 8/16/09–3/20/11 and followed them until 9/30/11 for colonoscopy completion or 
documentation of potentially valid reasons for not completing colonoscopy. As described 
previously,19 we identified FOBT/FIT+ results from VHA laboratory records, using the 
codes in Supplementary Material 1. We defined FOBT/FIT+ cases as any individual or 
multiple card series with one or more positive result cards. We restricted the sample to 
patients receiving FOBT/FIT+ results from facilities that conducted at least 1,400 FOBTs in 
2009 to permit rigorous examination of facility-level variation in follow-up colonoscopy.19 
We excluded patients if they were less than 50 or more than 85 years of age at the time of 
the FOBT/FIT+ result; had a diagnosis of colorectal cancer; or died during the follow-up 
interval. To minimize the number of cases with missing data, we also excluded patients that 
received their FOBT/FIT+ from a VHA Community Based Outpatient Clinic (CBOC) 
referring <70% of colonoscopies to one of the sampled facilities, or from a facility where 
>90% of cases were missing clinical notes data used to assess refusal and private sector 
colonoscopy use. Using these criteria, we identified 76,243 FOBT/FIT+ cases from 120 
VHA facilities for the analysis (Figure 1).
Data sources and measures
The dependent measure for our analysis was a completed follow-up colonoscopy at a VHA 
facility within 6 months of the FOBT/FIT+ date. We used this follow-up window because, 
consistent with prior studies,10 most individuals in the VHA completing colonoscopy 
following FOBT/FIT+ results do so within 6 months. We identified completed 
colonoscopies from VHA administrative data using the codes in Supplementary Material 2.
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Predictors—Guided by the Diagnostic Evaluation Model,20;21 we distinguish between 
patient, physician, and environmental predictors of follow-up. Patient factors examined 
consisted of: demographic and health characteristics, including race/ethnicity (Non-Hispanic 
White, Hispanic, Black, American Indian, Asian or Pacific Islander), gender, age (50–59, 
60–64, 65–75, 76–85), and marital status (married, widowed, other); Charlson comorbidity 
score for the 1 year prior to the FOBT/FIT+ result (0, 1–2, 3 or higher); mental health 
diagnoses (psychiatric only, substance abuse only, dual diagnosis, or none); personal history 
of colorectal polyps or benign neoplasms (ICD-9 211.3–4, 569.0, v12.72); and behaviors 
(colonoscopy refusal, use of private sector colonoscopy for follow-up). We used Statistical 
Text Mining (STM) to identify documentation of refusal and private colonoscopy, using a 
validated algorithm, described previously.19 This algorithm searched consult, progress, 
primary care and clinical reminder notes entered during the follow-up interval for key 
phrases associated with refusal or private sector colonoscopy use, and assigned each FOBT
+/FIT+ case with two continuous scores: one corresponding to the probability that their 
notes contain documentation of refusal, and one corresponding to the probability that their 
notes contained documentation of private sector colonoscopy use. We used the probabilities 
from STM to assign refusal and private sector colonoscopy status to each individual without 
VHA follow-up. The distributions for these probabilities were disparate and tended toward 
extreme values. Our intent was to gauge the sensitivity of the initial findings to these 
unobserved outcomes; so rather than performing a complex Monte Carlo simulation study, 
we classified notes with a refusal probability ≥0.60 as indicating the patient refused follow-
up and notes with a private sector colonoscopy probability ≥0.93 as indicating the patient 
pursued private sector colonoscopy. We selected these thresholds based on the probability 
distributions (see Figures S1, S2).
Physician factors: Physician factors examined included: physician characteristics, such as 
FOBT/FIT ordering provider training (physician, nurse practitioner or physician assistant, 
resident, nurse or other staff), and whether the ordering physician was the patient’s primary 
care provider; and the physician behavior of potentially inappropriate screening (i.e., patient 
has limited life expectancy, VHA colonoscopy in prior 10 years).
Environmental factors: Environmental factors examined consisted of geographic access 
indicators, including residence (urban, rural) and drive time to the nearest VHA specialty 
care facility (<30, 30–60, >60 minutes), and FOBT/FIT ordering facility type (specialty care 
or CBOC). We used administrative data to identify all predictors.
Analysis
We used hierarchical regression, modeling the odds of completing follow-up colonoscopy 
within six months to identify individual-level predictors of follow-up. These models 
incorporated random effects for facility and fixed effects for the measures in Table 1. To 
select variables for the final model, we used a bootstrap resampling model selection 
algorithm.22 This involved constructing 500 bootstrap samples, using a forward selection 
algorithm with each individual sample to develop a bootstrapped model, and retaining 
predictors selected in 90% of these models for inclusion in the final model. From this final 
model we constructed model-based odds ratios and least square mean follow-up estimates 
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for each measure (using the observed marginal distributions of other covariates). We did not 
hypothesize interactions between predictors and therefore did not include interaction terms 
in the model.
To assess the sensitivity of estimates to patient and physician behaviors that might explain 
lack of VHA follow-up, we reran our models excluding cases potentially screened 
inappropriately (n=343 with limited life expectancy, and n=11,987 with a prior 
colonoscopy), and treating those refusing (n=7,708), pursuing private sector colonoscopy 
(n=8,666) or both (n=2,510) as having received follow-up.
This study was reviewed and approved by the institutional review boards at the Minneapolis 
and Boston VA Healthcare Systems.
RESULTS
Patients were primarily non-Hispanic white (65%) men (96%) age 50–75 (89%) (Table 1). 
Roughly half (54%) were married, 27% had three or more comorbidities, 68% had a mental 
health or substance abuse diagnosis, and 20% had a personal history of polyps. The majority 
had their FOBT/FIT ordered by a physician (72%) who was their primary care provider 
(72%). Less than 1% had limited life expectancy, and 16% had a VHA colonoscopy in the 
prior 10 years. Roughly half (51%) lived in rural areas, 42% lived more than 60 minutes 
away from the nearest VHA specialty care facility, and 57% had their FOBT/FIT ordered at 
a CBOC.
Among the 76,243 FOBT/FIT+ cases identified, 38,005 (50%) completed a colonoscopy at a 
VHA facility within 6 months; 7,294 (10%) did not complete a colonoscopy but were 
potentially inappropriately screened, due either to limited life expectancy (0.27%) or a 
recent prior colonoscopy at a VHA facility (9.29%); up to 13,863 (18%) did not complete a 
colonoscopy but either refused a VHA colonoscopy (7%), pursued a private sector 
colonoscopy (8%), or both (3%); and at least 17,010 (22%) had no reason documented for 
not completing a colonoscopy.
With the exception of gender, residence, and provider type, all factors examined were 
significantly associated with follow-up rates in univariate models (Table 2). Patient factors 
retained in the multivariate model included: race/ethnicity, age, personal history of polyps, 
and comorbidity score. Age (odds ratios 2.01–3.10 for the younger versus oldest age 
category) was a strong independent predictor, corresponding to follow-up rate differences as 
large as 29 percentage points. Personal history of polyps (odds ratio 2.57) was positively 
associated, and the Charlson score negatively associated with follow-up. Those with a 
Charlson score of 3+ had follow-up rates 5 percentage points lower than those with a score 
of zero (46 versus 51%). We found a small reverse race disparity, with Blacks demonstrating 
follow-up rates 4 percentage points higher than Whites.
Physician factors
Those whose FOBT/FIT was ordered by their primary care provider had follow-up rates that 
were 7 percentage points higher than those whose FOBT/FIT was not ordered by their 
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primary care provider. Colonoscopy in the prior 10 years (odds ratio 1.66) was the only 
indicator of potentially inappropriate screening included in the multivariate model. Those 
with no prior colonoscopy in the past 10 years had a follow-up rate 12 percentage points 
higher than those with a prior colonoscopy (51 versus 39%, respectively).
Environmental factors
No geographic access measures were retained in the multivariate model, but those whose 
FOBT/FIT was ordered at a specialty care facility had follow-up rates that were 7 percentage 
points higher than those whose FOBT/FIT was ordered at a CBOC.
After excluding potentially inappropriately screened individuals and treating patients 
refusing colonoscopy or pursuing colonoscopy in the private sector as followed-up, the small 
differences by race/ethnicity attenuate further (Figure 2, Table S1), and the differences by 
age (Figure 3, Table S1) and Charlson score (Figure 4, Table S1) attenuate markedly. Patient 
behavior (refusals and private sector colonoscopy use) contributed more to the variation in 
follow-up rates by age, race, and Charlson score than physician behavior (inappropriate 
screening), although all three increased with age and Charlson score, and were more 
common among Whites than Blacks (Figures 2–4).
DISCUSSION
We found that 50% of the FOBT/FIT+ cases completed a follow-up colonoscopy in the 
VHA within 6 months; that age and comorbidities were negatively associated with follow-
up; and that Blacks were more likely to receive follow-up in the VHA than Whites. 
Multivariate models controlling for environmental factors, including geographic access, 
attenuated but did not fully account for these differences. Adjusting for patient behaviors 
(refusal, and private sector colonoscopy use), and physician behaviors (potentially 
inappropriate screening) fully accounted for the small reverse race disparity, and markedly 
attenuated variation by age and comorbidities.
The contribution of potentially inappropriate screening due to recent prior colonoscopy to 
follow-up rates we observed is consistent with findings from prior studies, including one that 
identified recent colonoscopy as a prevalent reason for failure to complete follow-up,12 and 
two that found a strong association between colonoscopy history and FOBT/FIT+ follow-
up.15;16 As documented in prior studies conducted on samples age 50–75,23 potentially 
inappropriate screening due to limited life expectancy was relatively rare in our sample 
(<1%).17 The frequency of refusal among those failing to complete a colonoscopy we 
observed (14–21% depending on whether those who refused are combined with those who 
both refused and had private sector colonoscopy access) is similar to colonoscopy follow-up 
refusal rates reported in prior studies (range 7–26%).12;16;17;24;25
Although prior studies have documented lower rates of colorectal cancer screening26 and 
surveillance27 among racial and ethnic minority groups, findings regarding race/ethnic 
variation in colonoscopy follow-up for FOBT/FIT+ results are mixed. One prior study 
conducted in a community practice12 found lower follow-up rates among Hispanics, but 
most prior studies have either found no evidence of race/ethnic variation in follow-up,5;10;28 
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or higher follow-up among minorities.16;29;30 Additionally, in contrast with prior studies 
documenting higher refusal among Blacks for invasive procedures and treatments, including 
coronary angiography31–34 and revascularization,32;35 we found lower refusal rates among 
Blacks than Whites. This may in part reflect the fact that Blacks are more likely to rely 
solely on VHA care36–42, and therefore may be less likely to refuse due to access to private 
sector colonoscopy. The race variation in use of VHA care may be explained in part by well-
documented race variation in income, education, and insurance coverage, all of which are 
positively associated with greater use of non-VHA care among Veterans.37;39;40
Our finding that age and comorbidities were negatively associated with follow-up is 
consistent with prior studies.5;10;13;16;24;43 Studies finding no significant association 
between follow-up and these factors either restricted the sample to the oldest age groups17 or 
excluded those over 75.6;12;15;44 It is not clear why the effects of age and comorbidity on 
follow-up were not fully explained by other patient characteristics, patient behaviors 
(refusal, private sector colonoscopy use), physician behaviors (inappropriate screening), or 
environmental factors. Possible explanations include: lower patient and provider motivation 
to aggressively pursue follow-up under circumstances of advanced age or severe 
comorbidity due to lower perceived benefits and greater perceived risks of colonoscopy; 
greater likelihood that those with advanced age and severe comorbidity experience acute 
health challenges and logistical barriers that compete with follow-up; or a failure to capture 
all refusal, private sector colonoscopy, and inappropriate screening with the measures 
employed.
This study has a number of strengths, including a large, nationally representative sample of 
patients and facilities; rigorous methodology for assessing the impact of inappropriate 
screening, refusal, and private sector colonoscopy use on variation in follow-up rates by 
patient demographic and health characteristics; and the ability to examine the association 
between environmental factors and follow-up rate estimates. However, we were not able to 
assess patient psychosocial reasons for lack of follow-up. Understanding the contribution of 
patient perspectives and experiences will likely be critical to developing effective 
interventions to improve follow-up rates. We also might have overestimated inappropriate 
screening, given that some consider FOBT/FIT screening conducted more than five years 
after a prior colonoscopy as clinically appropriate. Additionally, because we did not link our 
sample with private sector medical records, our assumption that patients pursuing 
colonoscopy in the private sector actually completed a colonoscopy might lead to 
overestimates of follow-up rates. However, the fact that another study found only 2% of 
patients not completing a VHA colonoscopy who said they were pursuing colonoscopy in 
the private sector lacked a Medicare claim for a colonoscopy17 suggests this overestimate is 
likely small. Finally, the VHA population is unique and may not generalize to other settings. 
However, as the largest integrated health care system in the US, the VHA population does 
generalize to a substantial number of individuals, including non-VHA Medicare beneficiary 
populations.45
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CONCLUSIONS
In the VHA setting, Blacks are more likely to receive colonoscopy follow-up for FOBT/FIT
+ results than Whites, and follow-up rates significantly decline with advancing age and 
comorbidity burden. Patient behaviors (refusal, private sector colonoscopy use) and 
physician behaviors (inappropriate screening) explain race/ethnicity variation in follow-up 
rates and contribute to variation by age and comorbidity burden.
IMPLICATIONS FOR PRACTICE
Our finding that geographic access metrics were not significant predictors of follow-up 
suggest that policies such as the Veteran Choice and Accountability Act, which expand 
geographic access for Veterans by purchasing care from private sector providers, may not 
fully address existing gaps in follow-up. Inappropriate screening is an important, modifiable 
physician behavioral barrier to improving follow-up rates, and future efforts to optimize 
follow-up would benefit from implementing methods to reliably exclude those with recent 
colonoscopy from clinical reminders and other tools designed to prompt physicians to 
initiate colorectal cancer screening. The VHA has a system in place for tracking patients 
with positive FOBT/FIT screens at the facility-level, but the extent to which this tool is used, 
and whether and how well non-VHA colonoscopies are tracked at the facility level is 
unknown. Future improvement efforts might seek to enhance functionality of this tool by 
assessing whether and how accurately non-VHA colonoscopy information is included, and 
to encourage its use through leadership and resource support. Additional improvement 
efforts might evaluate approaches to reduce inappropriate screening. Implementing a 
centralized eligibility assessment and tracking system that incorporates information on prior 
colonoscopy history, age, comorbidities and/or life expectancy, is one promising strategy to 
explore.
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Precis
In the Veterans Health Administration, Blacks are more likely to receive colonoscopy 
follow-up for positive Fecal Occult Blood Test/Fecal Immunochemical Test (FOBT/FIT
+) results than Whites, and follow-up rates decline with advancing age and comorbidity 
burden. Patient behaviors (refusal, private sector colonoscopy use), and physician 
behaviors (inappropriate screening) explain race variation in follow-up rates and 
contribute to age and comorbidity variation.
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Figure 1. 
Subject Flowchart
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Figure 2. 
Multivariate and sensitivity-adjusted colonoscopy completion rates by race/ethnicity
Partin et al. Page 14
Cancer. Author manuscript; available in PMC 2018 September 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. 
Multivariate and sensitivity-adjusted colonoscopy completion rates by age
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Figure 4. 
Multivariate and sensitivity-adjusted colonoscopy completion rates by Charlson score
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TABLE 1
Participant Characteristics (N=76,243)
Characteristics N (%)
Patient characteristics
Race/ethnicity
 Asian/Pacific Islander 1,013 (1.33)
 Black 13,618 (17.86)
 Native American 644 (0.84)
 White, Non-Hispanic 49,692 (65.18)
 Hispanic 4,097 (5.37)
 Unknown 7,179 (9.42)
Gender
 Male 73,487 (96.39)
 Female 2,756 (3.61)
 Missing 0
Age
 50–59 22,827 (29.94)
 60–64 22,691 (29.76)
 65–75 22,106 (28.99)
 76–85 8,619 (11.3)
 Missing 0
Marital status
 Married 40,706 (53.57)
 Widowed 4,313 (5.68)
 Others 30,964 (40.75)
 Missing 260
Charlson score
 0 23,260 (30.51)
 1 18,608 (24.41)
 2 13,572 (17.8)
 3+ 20,803 (27.29)
 Missing 0
Mental health diagnoses
 None 24,513 (32.15)
 Psychiatric only 19,791 (25.96)
 Substance abuse only 11,875 (15.58)
 Both 20,064 (26.32)
 Missing 0
Polyps diagnosis
 NO 60,723 (79.64)
 YES 15,520 (20.36)
 Missing 0
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Characteristics N (%)
Physician characteristics
FOBT ordering provider is primary care provider
 NO 21,307 (27.95)
 YES 54,936 (72.05)
 Missing 0
FOBT ordering provider type
 Physician 54,825 (71.92)
 Non-physician (NP, PA) 17,408 (22.84)
 Resident 2,430 (3.19)
 other 1,563 (2.05)
 Missing 17 (0.02)
Physician behaviors (Inappropriate screening)
Patient has limited Life Expectancy
 NO 75,801 (99.42)
 YES 442 (0.58)
 Missing 0
Patient had VHA Colonoscopy <10 years ago
 NO 64,256 (84.28)
 YES 11,987 (15.72)
 Missing 0
Environmental factors
Residence
 Rural/highly rural 38,423 (50.58)
 Urban 37,539 (49.42)
 Missing 281
Drive time to specialty care facility
 >60 minutes 31,756 (41.8)
 30–60 minutes 17,621 (23.2)
 <30 minutes 26,591 (35)
 Missing 275
Ordering facility type
 Specialty care facility 33,141 (43.47)
 CBOC 43,102 (56.53)
 Missing 0
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Table 2
Odds ratios, 95% confidence intervals, and follow-up rate estimates from univariate and multivariate 
hierarchical logistic regression models.
Univariate Multivariate
Odds ratio (95% CI) Follow-up % Odds ratio (95% CI) Follow-up %
Patient characteristics
Race White 1.00 48 1.00 49
  Asian/PI 1.07 (0.94–1.22) 49 1.05 (0.92–1.19) 50
  Black 1.33 (1.28–1.39) 55 1.19 (1.14–1.25) 53
  Hispanic 1.17 (1.08–1.27) 52 1.09 (1.00–1.19) 51
  Native American 1.18 (1.00–1.38) 52 1.12 (0.95–1.32) 51
  Unknown 0.83 (0.78–0.87) 43 0.81 (0.77–0.86) 43
Gender Female 1.00 48 — —
 Male 1.02 (0.95–1.11) 49 — —
Age 76–85 1.00 27 1.00 29
 50–59 3.43 (3.24–3.62) 56 3.10 (2.93–3.29) 56
 60–64 3.11 (2.94–3.28) 54 2.89 (2.73–3.06) 54
  65–75 2.11 (2.0–2.24) 44 2.01 (1.90–2.13) 45
Marital status Other 1.00 51 — —
  Married 0.85 (0.83–0.88) 47 — —
  Widowed 0.72 (0.67–0.76) 43 — —
Mental Health dx - dual 1.00 52 — —
  None 0.77 (0.75–0.80) 45 — —
  Psychiatric only 0.87 (0.83–0.90) 48 — —
  Substance Abuse only 0.99 (0.95–1.04) 51 — —
Polyp No 1.00 44 1.00 44
  Yes 2.23 (2.15–2.32) 64 2.57 (2.47–2.67) 67
Charlson 3+ 1.00 43 1.00 46
  0 1.50 (1.44–1.56) 53 1.23 (1.18–1.28) 51
  1 1.35 (1.30–1.41) 50 1.17 (1.12–1.22) 50
  2 1.24 (1.18–1.29) 48 1.13 (1.08–1.19) 49
Physician characteristics
Provider type other 1.00 47 — —
 Non-Physician (NP, PA) 1.07 (0.96–1.20) 49 — —
 Physician 1.09 (0.97–1.21) 49 – —
 Resident 0.94 (0.82–1.08) 45 — —
Ordering provider not PCP 1.00 44 1.00 44
  Is PCP 1.29 (1.24–1.33) 50 1.29 (1.24–1.34) 51
Physician behaviors
Limited life expectancy- no 1.00 49 — —
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Univariate Multivariate
Odds ratio (95% CI) Follow-up % Odds ratio (95% CI) Follow-up %
  Yes 0.55 (0.45–0.68) 34 — —
Colonoscopy <10 yrs Yes 1.00 41 1.00 39
  No 1.47 (1.41–1.53) 50 1.66 (1.58–1.73) 51
Environmental factors
Residence Urban 1.00 49 — —
 Rural 0.97 (0.94–1.00) 48 — —
Drive time >60 minutes 1.00 46 — —
 30–60 1.17 (1.12–1.21) 50 — —
  <30 1.23 (1.19–1.30) 51 — —
Ordering facility CBOC 1.00 45 1.00 45
  Specialty care hospital 1.26 (1.22–1.30) 51 1.32 (1.28–1.36) 52
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